\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ none\\ required\ \(5\)\
\-\ two\\ enhancing\\ foci\\ in\\ the\\ brain\\ stem\\;\\ one\\ within\\ right\\ side\\ of\\ mid\\ brain\\ and\\ the\\ second\\ within\\ the\\ pons\\.\ \(0\)\
\-\ minimal\\ focal\\ enlargement\\ of\\ pons\\.\\ \\ no\\ evidence\\ of\\ prior\\ hemorrhage\\.\ \(0\)\
\-\ capillary\\ telangiectasia\ \(3\)\
\-\ developmental\\ venous\\ angioma\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ demylinating\\ plaque\ \(0\)\
\-\ 32\\ year\\ old\\ man\\ for\\ evaluation\\ of\\ a\\ first\\ time\\ seizure\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pons\\:\\ 0\\.16840319969800593\ \(0\)\
\-\ demylinating\\:\\ 0\\.12424276744021376\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.0994999307972944\ \(0\)\
\-\ plaque\\:\\ 0\\.0888268409971871\ \(0\)\
\-\ brain\\:\\ 0\\.0886672939069918\ \(0\)\
\-\ stem\\:\\ 0\\.0875491173393643\ \(0\)\
\-\ capillary\\:\\ 0\\.08674704810427994\ \(0\)\
\-\ angioma\\:\\ 0\\.08635958507234791\ \(0\)\
\-\ 32\\:\\ 0\\.07347657814424065\ \(0\)\
\-\ developmental\\:\\ 0\\.06847122995703288\ \(0\)\
\-\ seizure\\:\\ 0\\.06514768657849775\ \(0\)\
\-\ foci\\:\\ 0\\.06324179219229388\ \(0\)\
\-\ mid\\:\\ 0\\.06161674842942855\ \(0\)\
\-\ enlargement\\:\\ 0\\.05845807597388095\ \(0\)\
\-\ minimal\\:\\ 0\\.058008275351737894\ \(0\)\
\-\ second\\:\\ 0\\.056588429917913415\ \(0\)\
\-\ within\\:\\ 0\\.05621142787538212\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.05441441738287719\ \(0\)\
\-\ venous\\:\\ 0\\.05347906238719188\ \(0\)\
\-\ required\\:\\ 0\\.05302975020322869\ \(0\)\
\-\ side\\:\\ 0\\.051042181064897774\ \(0\)\
\-\ first\\:\\ 0\\.04943936956527331\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.04903890662372475\ \(0\)\
\-\ enhancing\\:\\ 0\\.046206095394564814\ \(0\)\
\-\ evaluation\\:\\ 0\\.04279722061770358\ \(0\)\
\-\ two\\:\\ 0\\.042195366165793204\ \(0\)\
\-\ focal\\:\\ 0\\.042077475933420726\ \(0\)\
\-\ time\\:\\ 0\\.04161381426274677\ \(0\)\
\-\ one\\:\\ 0\\.03992640316052835\ \(0\)\
\-\ evidence\\:\\ 0\\.038628320402877205\ \(0\)\
\-\ prior\\:\\ 0\\.03782953055521316\ \(0\)\
\-\ metastatic\\:\\ 0\\.03708809316579466\ \(0\)\
\-\ none\\:\\ 0\\.036546888050138046\ \(0\)\
\-\ \\;\\:\\ 0\\.03492105497332058\ \(0\)\
\-\ man\\:\\ 0\\.03484365246706895\ \(0\)\
\-\ disease\\:\\ 0\\.024081681745098348\ \(0\)\
\-\ year\\:\\ 0\\.016484573608153703\ \(0\)\
\-\ right\\:\\ 0\\.015545374295007184\ \(0\)\
\-\ old\\:\\ 0\\.015085079256245769\ \(0\)\
\-\ no\\:\\ 0\\.014835243977651758\ \(0\)\
\-\ for\\:\\ 0\\.01257083014901233\ \(0\)\
\-\ of\\:\\ 0\\.008034744882619892\ \(0\)\
\-\ in\\:\\ 0\\.007265469485176809\ \(0\)\
\-\ the\\:\\ 0\\.007150825070877196\ \(0\)\
\-\ a\\:\\ 0\\.006837927617562091\ \(0\)\
\-\ and\\:\\ 0\\.0031036035471072145\ \(0\)\
\-\ \\.\\:\\ 0\\.002448243868782502\ \(0\)\
